Stefanie Deuster

545 total citations
14 papers, 378 citations indexed

About

Stefanie Deuster is a scholar working on Biomaterials, Cognitive Neuroscience and Oncology. According to data from OpenAlex, Stefanie Deuster has authored 14 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biomaterials, 3 papers in Cognitive Neuroscience and 3 papers in Oncology. Recurrent topics in Stefanie Deuster's work include Nanoparticle-Based Drug Delivery (3 papers), Muscle Physiology and Disorders (2 papers) and HER2/EGFR in Cancer Research (2 papers). Stefanie Deuster is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Muscle Physiology and Disorders (2 papers) and HER2/EGFR in Cancer Research (2 papers). Stefanie Deuster collaborates with scholars based in Switzerland, Canada and United Kingdom. Stefanie Deuster's co-authors include Reto Ritschard, Christoph Rochlitz, Christoph Mamot, Andreas Wicki, Lukas Bubendorf, Thomas Dieterle, Richard Herrmann, Arne Fischmann, Leo H. Bonati and Michael Sinnreich and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Stefanie Deuster

14 papers receiving 373 citations

Peers

Stefanie Deuster
Peng Ding China
Stefanie Deuster
Citations per year, relative to Stefanie Deuster Stefanie Deuster (= 1×) peers Peng Ding

Countries citing papers authored by Stefanie Deuster

Since Specialization
Citations

This map shows the geographic impact of Stefanie Deuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Deuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Deuster more than expected).

Fields of papers citing papers by Stefanie Deuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Deuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Deuster. The network helps show where Stefanie Deuster may publish in the future.

Co-authorship network of co-authors of Stefanie Deuster

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Deuster. A scholar is included among the top collaborators of Stefanie Deuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Deuster. Stefanie Deuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Heravi, Ala Taji, Stefanie Deuster, Stuart McLennan, et al.. (2022). Investigational medicinal products, related costs and hospital pharmacy services for investigator-initiated trials: A mixed-methods study. PLoS ONE. 17(3). e0264427–e0264427. 1 indexed citations
2.
Mitter, Vera Ruth, et al.. (2021). Die Rolle der Spitalapotheke in klinischen Studien. Schweizerische Ärztezeitung. 1 indexed citations
3.
Mitter, Vera Ruth, et al.. (2021). Die Rolle der Spitalapotheke in klinischen Studien. Bulletin des Médecins Suisses. 1 indexed citations
4.
Speich, Benjamin, Patrícia Logullo, Stefanie Deuster, et al.. (2020). A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials. Journal of Clinical Epidemiology. 131. 70–78. 7 indexed citations
6.
Deuster, Stefanie, et al.. (2017). Stability testing of piperacilline/tazobactam in elastomeric infusion pumps. Le Pharmacien Hospitalier et Clinicien. 52(1). e32–e32. 4 indexed citations
7.
Hafner, Patricia, Leo H. Bonati, Beat Erne, et al.. (2016). Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study. PLoS ONE. 11(1). e0147634–e0147634. 65 indexed citations
8.
Wicki, Andreas, et al.. (2015). Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: Production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial. International Journal of Pharmaceutics. 484(1-2). 8–15. 31 indexed citations
9.
Bonati, Leo H., Patricia Hafner, Beat Erne, et al.. (2015). Improved Muscle Function in Duchenne Muscular Dystrophy using a Combination of L-Arginine and Metformin. Neuropediatrics. 46(S 01). 3 indexed citations
10.
Mamot, Christoph, Reto Ritschard, Andreas Wicki, et al.. (2012). Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study. The Lancet Oncology. 13(12). 1234–1241. 179 indexed citations
11.
Hardmeier, Martin, Ronan Zimmermann, Stephan Rüegg, et al.. (2012). Intranasal Midazolam: Pharmacokinetics and Pharmacodynamics Assessed by Quantitative EEG in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 91(5). 856–862. 26 indexed citations
12.
Ruppen, Wilhelm, et al.. (2011). Dose calculation in opioid rotation: electronic calculator vs. manual calculation. International Journal of Clinical Pharmacy. 33(1). 25–32. 11 indexed citations
13.
Mamot, Christoph, Reto Ritschard, Thomas Dieterle, et al.. (2011). A phase I study of doxorubicin-loaded anti-EGFR immunoliposomes in patients with advanced solid tumors.. Journal of Clinical Oncology. 29(15_suppl). 3029–3029. 9 indexed citations
14.
Deuster, Stefanie, et al.. (2009). Implementation of treatment guidelines to support judicious use of antibiotic therapy. Journal of Clinical Pharmacy and Therapeutics. 35(1). 71–78. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026